Immunitybio Inc (IBRX)

Financing Cash Flow

$44.44M

Quarterly · Period ending: · USD

IBRX logo

IBRX Financing Cash Flow

Latest reported$44.44M
IBRX Quarterly Cash from Financing (-$165.00K → $44.44M)
High-resolution chart · PNG

IBRX financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
44,443,000
223,926,000
54,894,000
173,519,000
172,810,000
-982,000
106,929,000
15,582,000
148,894,000
10,225,000
200,539,000
237,502,000
43,412,000
76,888,000
109,940,000
123,986,000
-15,000
-298,000
325,953,000
42,656,000
98,337,000
38,497,000
241,000
63,217,000
87,340,000
-123,000
-61,000
-40,000
-501,000
39,195,000
-370,000
-115,000
-201,000
-85,000
-3,142,000
-14,947,000
-16,426,000
-468,000
-4,104,000
-2,991,000
-6,575,000
-1,890,000
306,000
243,079,000
73,970,000
-22,000
58,529,000
127,000
5,916,000
-165,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.